Portrait of Fernando Urrego
  • Telehealth visits
bch logo

Fernando Urrego, MD, MPH

Pediatric Pulmonology
Portrait of Fernando Urrego
Portrait of Fernando Urrego
bch logo

Fernando Urrego, MD, MPH

Pediatric Pulmonology
  • Telehealth visits

On this page

About me

Dr. Fernando Urrego is a pediatric pulmonologist who cares for infants, children and adolescents with acute or chronic respiratory conditions. His expertise includes treating asthma, lung prematurity, cystic fibrosis, wheezing and chronic cough. He also cares for patients who have a tracheostomy (a surgically made opening in the windpipe) and those who depend on a ventilator.

In research, Urrego focuses on improving the quality of patient care and addressing health disparities.

Urrego earned his medical degree from Escuela de Medicina Juan N. Corpas in Bogotá, Colombia. He completed a pediatric residency at the University of Tennessee Health Science Center, followed by a pediatric pulmonology fellowship at the University of Miami Miller School of Medicine. He also has a master of public health degree from Tulane University School of Public Health and Tropical Medicine.

Education & training

Board certification

  • Pediatric Pulmonology, American Board of Pediatrics

Fellowship

  • Pediatric Pulmonology, University of Miami - Miller School of Medicine

Residency

  • Pediatrics, University of Tennessee at Chattanooga

Internship

  • Pediatrics, University of Tennessee at Chattanooga

Degree

  • MD, Juan N. Corpas Scl. of Medicine

Academic Title

  • Health Sciences Clinical Professor

My expertise

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.